Maria Mattheijssens
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat Expansion.
Journal: JAMA neurology
Published: February 14, 2017
Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
Journal: Neuroscience letters
Published: May 10, 2016
Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation.
Journal: Neurology
Published: October 11, 2015
Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort.
Journal: Brain : a journal of neurology
Published: July 23, 2015
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort.
Journal: Neurology
Published: May 19, 2015
The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.
Journal: Molecular psychiatry
Published: May 12, 2015
Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.
Journal: The Lancet. Neurology
Published: March 27, 2015
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration.
Journal: Acta neuropathologica
Published: February 10, 2014
Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
Journal: JAMA neurology
Published: January 23, 2013
C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment.
Journal: Neurobiology of aging
Published: December 19, 2012
Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population.
Journal: Neurobiology of aging
Published: December 26, 2011
Last Updated: 09/26/2026